Viewing Study NCT01379469

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-05-26 @ 12:06 PM
Study NCT ID: NCT01379469
Status: TERMINATED
Last Update Posted: 2021-10-12
First Post: 2011-06-15
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
Sponsor: Washington University School of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alpha-1-antitrypsin Deficiency View
None Liver Cirrhosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Carbamazepine (Tegretol) use View
None severe liver disease View
None alpha-1-antitrypsin deficiency View